跳至主要内容
临床试验/EUCTR2017-001798-18-Outside-EU/EEA
EUCTR2017-001798-18-Outside-EU/EEA进行中(未招募)1 期

Partnership for Research on Ebola VACcinationsP/0307/2021P/0334/2021 - PREVAC

Inserm0 个研究点开始时间: 2017年5月10日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
Inserm

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Informed consent/assent
  • - Age greater than or equal to 1 year
  • - Planned residency in the area of the study site for the next 12 months
  • - Willingness to comply with the protocol requirements
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 1400
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 3450
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 50

排除标准

  • - Fever greater than 38º Celsius
  • - History of EVD (self-report)
  • - Pregnancy (a negative urine pregnancy test is required for females of child-bearing potential, i.e., females who have experienced menarche or who are aged 14 years and older)
  • - Positive HIV test for participants less than 18 years of age
  • - Reported current breast-feeding
  • - Prior vaccination against Ebola (self-report)
  • - Any vaccination in the past 28 days or planned within the 28 days after randomization (initial vaccination)
  • - In the judgement of the clinician, any clinically significant acute/chronic condition that would limit the ability of the participant to meet the requirements of the study protocol

研究者

发起方
Inserm

相似试验